CMPX
Compass Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website compasstherapeutics.com
- Employees(FY) 26
- ISIN US20454B1044
Performance
-0.65%
1W
+108.11%
1M
+80.12%
3M
+170.18%
6M
+112.41%
YTD
+136.92%
1Y
Profile
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 a ligand of Notch-1, and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells. It also develops CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1 checkpoint inhibitor antibodies. Compass Therapeutics, Inc. was founded in 2014 and is headquartered in Boston, Massachusetts.
Technical Analysis of CMPX 2025-02-03
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2023-11-08 19:17
- 2023-11-08 18:30
- 2023-11-06 19:00
- 2023-08-29 20:00
- 2023-08-02 20:00
- 2023-06-22 04:05
- 2023-05-31 22:06
- 2023-05-03 20:30
- 2023-04-25 20:30
- 2023-04-18 20:30
- 2023-03-27 20:30
- 2023-03-14 20:30
- 2023-02-15 18:28
Daily Vickers Top Buyers & Sellers for 02/16/2023(Yahoo Finance)
- 2023-02-01 19:30
- 2023-01-24 17:39
Daily Vickers Top Buyers & Sellers for 01/25/2023(Yahoo Finance)
- 2023-01-19 04:00
- 2023-01-05 19:30
- 2022-12-14 19:30
- 2022-11-30 19:30
- 2022-11-21 19:00
- 2022-11-08 20:00
- 2022-11-07 19:00
- 2022-11-01 21:06
Compass Therapeutics Announces $80 Million Private Placement(Yahoo Finance)
- 2022-10-10 20:00
- 2022-09-08 20:00
- 2022-08-01 20:00
- 2022-07-31 20:00
- 2022-07-17 19:05
- 2022-05-30 20:00
- 2022-05-22 20:00
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.